Introduction
The rosette inhibition test was originally described by Bach and Anitoine (1968) as an in-vitro method of assessing the activity of antilymphocyte globulin (A.L.G.). The test depends on the spontaneous formation of rosettes of sheep red blood cells around human lymphocytes in vitro. The addition of A.L.G. to this system inhibits rosette formation. By using a range of doubling dilutions of A.L.G. and counting rosettes per 1,000 lymphocytes at each dilution a rosette inhibition curve can be drawn ( fig. 1 ). The rosette inhibition titre is taken at the point on the curve where there is a 25 % reduction in numbers of rosettes compared with a control sample with no A.L.G.
Munro et al. (1971) described the use of the test in predicting acute rejection episodes in renal transplant patients. It was shown that in immunosuppressed patients and in patien-ts with impaired immune status such as those with chronic renal failure, there was a shift of the rosette inhibition curve to the right with a consequent rise in titre. It was also shown that before biochemical evidence of a rejection episode the curve shifted back to the left with a fall in the rosette inhibition titre to normal levels ( fig. 2) . We have used the test in 14 normal subjects, eight dialysis patients, and 11 renal transplant patients in an attempt to confirm these findings.
Materials and Methods
The technique used was basically that originally described by In practice, observer error is one of the greatest problems in the test. In an unstained preparation rosettes are fairly readily seen but lymphocytes are often difficult to identify with certainty. A series of 20 paired tests were performed to estimate reliability and observer error. In only 14 (70%) of the paired tests was the same rosette inhibition titre achieved. In four of the tests there was one dilution difference in titre and in two of the itests two dilutions of difference. The total observer error was 15%, with a lymphocyte counting error of 20% and a rosette countin-g error of 8%. The tests were counted by four observers who all had wide experience with the test.
Staining of the unfixed preparation did not improve our resulits. Unfortunately both methylene blue and toluidine blue inhibit rosette formation when used in sufficient concentration to stain the lymphocytes. Trypan blue is unisatisfactory because most of the lymphocytes remain viable. Eosin staining of the red cells is equally unsatisfactory because the prominent pink background still makes it difficult to identify the lymphocytes. We found three ways of reducing observer error to acceptable levels. Firstly, by counting rosettes in the noraml way and then taking a separate sample from each diluttion tube and performing a normal white count with diluting fluid. Phase contrast microscopy is also effective in reducing observer error. Undoubtedly the most accurate method is to fix the preparation with glutaraldehyde and then stain the lymphocytes wifth trypan blue (Haskill et al., 1972) . However, the technique is timeconsuming and not really suitable for daily testing with a range of A.L.G. dilutions.
Discussion
The prediction and even the diagnosis of renal transplant rejection still present problems despite the introduction of a variety of tests. On a theoretical basis, tests detecting changes in the lvmphocyte population would appear to offer the best chance of predicting impending rejection at the earliest stage.
The value of the leucocyte migration test in predicting rejection has already been established (Smith et al.. 1969 : Weeke et al. 1970 Falk et al., 1972; Galanaud et al., 1972; House et al., 1973; Wood et al., 1973 ). An increased spontaneous uptake of radioactive-labelled thvmidine in "activation lymphocytes" (Hersh et al., 1971) and an increase in lvmphoblast transformation in response to phvtohaemagglutinin (Rubin et al.. 1964; House et al., 1973) have both been shown to precede biochemical evidence of rejection. The rosette inhibirtion test was shown by Munro et al. (1971) to be of predictive value in the detection of rejection, and Bewick et al. (1972) described the use of the test in monitoring the level of immunosuppressive therapy. The advantage of the rosette inhibition test over these other techniques is the speed with which a result can be' obtained. It is possible to complete the test within four hours and this gives the prospect of a rapid confirmatory test in a patient who is thought to be rejecting on clinical or biochemical grounds. It was for this reason that we studied the test in postoperative renal transplant patients. Our re'ults have failed to confirm those of Munro et al. (1971) . In only two out of 12 rejection episodes was the test of predictive value, though in a further two rejection episodes titre levels fell at the time of rejection. There were a number of false positive results, and despite a study of the variables involved we were unable to improve significantly on the accuracv or reliability of the test.
The fact that there are changes in rosette inhibition titres with immunosuppressive therapy is noteworthy but at the present time the use of the test in the prediction of rejection is empirical. The phenomenon of spontaneous rosette formation of sht'ep red cells around human peripheral blood lvmphocvtes is still poorly unders,tood. In mice spontaneous rosette formaiion has b-en shown to be an effective T-cell marker (Rail', 1971) . Tn man, however, Chapel (1973) A fall in titre with rejection could be explained by the appearance of a population of immunocompetent T-cells directed against the graft. If the numbers of spontaneous rosette-forming cells in the control tubes reflected the level of T-cells in the peripheral blood then one might hope to predict rejection by a rise in the numbers of these cells. A review of all our results has failed to show any convincing evidence to support this. There was a fairly wide daily fluctuation in numbers of spontaneous rosette-forming cells of from 10 to 40% in control subjects. Technical considerations are probably the most important factor in ithis variation; different authors have found levels of spontaneous rosette-forming cells from 04 to 26% (Bach et al., 1969) up to 50 to 73% (Chapel, 1973) depending on experimental conditions.
In conclusion, a test which is to be used as the basis of the treatment of rejection should be both accurate and reproducible. Unfortunately, in its present form the rosette inhibition test satisfies neither of these criteria. A larger titre difference with immunosuppression and rejection would certainly improve the value of the test. We have tested a variety of A.L.G. preparaitions to look for bigger titre differences but none were distinctly superior to the Burroughs Wellcome A.L.G. in this respect. It would possibly be of benefit to have a freeze-dried A.L.G. preparation and test this against a bank of frozen reference cells to standardize the test.
